EICHOR
● Completed
A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Condition: Fuchs Endothelial Corneal Dystrophy · Sponsor: Kowa Research Institute, Inc.
About this study
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (50)
| Keck Hospital of USC | Los Angeles, California, United States | — |
| Macy Eye Center | Los Angeles, California, United States | — |
| Jules Stein Eye Institute | Los Angeles, California, United States | — |
| Byers Eye Institute at Stanford | Palo Alto, California, United States | — |
| Sacramento Eye Consultants | Sacramento, California, United States | — |
| Gorovoy MD Eye Specialists | Fort Myers, Florida, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| Bascom Palmer Eye Institute | Miami, Florida, United States | — |
| Bascom Palmer Eye Institute - Naples | Naples, Florida, United States | — |
| Eye Consultants of Atlanta | Atlanta, Georgia, United States | — |
| Grene Vision Group | Wichita, Kansas, United States | — |
| University of Kentucky | Lexington, Kentucky, United States | — |
+ 38 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.